About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72722 record(s)
Req # A-2023-001125
With respect to the Pfizer report entitled 125742_S1_M5_5351_bnt162-01-interim3-adverse-events, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified risks…Organization: Health Canada
March 2024
Req # A-2023-001157
Records detailing costs associated with personal drivers for your executive team. Include staffing costs for any drivers on-staff, or the costs of hiring them on a as-needed basis. Also include details for any vehicles purchased, or any vehicle…Organization: Health Canada
March 2024
Req # A-2023-001212
Any Screening Acceptance Letter sent by Health Canada to the sponsor of the Second Liraglutide Abbreviated New Drug Submission (ANDS).Organization: Health Canada
March 2024
Req # A-2023-001213
Screenshot of the status page for the Second Liraglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.Organization: Health Canada
March 2024
Req # A-2023-001216
An annotated copy of the most recent Certified Product Information Document (CPID) submitted for the Second Liraglutide Abbreviated New Drug Submission (ANDS).Organization: Health Canada
March 2024
Req # A-2023-001349
Number of individuals who have filed legal claims against their doctors involuntary detaining them at a psychiatric facility.Organization: Health Canada
March 2024
Req # A-2023-001370
The names and contact information of all the people who have been officially authorized to participate in the negotiations being conducted by the Working Group for amendments to the International Health Regulations (WGIHR). All official Letters of…Organization: Health Canada
March 2024
Req # A-2023-001394
All documentation that Health Canada considered when it decided to support the Diabetes Prevention Program as announced on June 25, 2019. All documentation demonstrating how Health Canada was engaged in, and monitored the progress of the study…Organization: Health Canada
March 2024
Req # A-2023-001405
All internal correspondence between Senior Health Canada management and any Members of Parliament who are also members of the New Democratic Party (NDP) between January 1, 2019 and January 31, 2024.Organization: Health Canada
March 2024
Req # A-2023-001411
Any communication between the Honorable Health Minister Mark Holland concerning the Canadian dental care plan from 2019 to 2024.Organization: Health Canada
March 2024